Validus (NYSE:VR) was downgraded by analysts at Buckingham Research from a “buy” rating to a “neutral” rating in a report issued on Tuesday, The Fly reports.
Several other equities research analysts also recently weighed in on VR. JMP Securities downgraded Validus from an “outperform” rating to a “market perform” rating in a report on Tuesday, January 30th. UBS Group upped their price target on Validus from $48.00 to $52.00 and gave the stock a “neutral” rating in a report on Monday, October 30th. Keefe, Bruyette & Woods downgraded Validus from an “outperform” rating to a “market perform” rating in a report on Monday, January 22nd. ValuEngine upgraded Validus from a “sell” rating to a “hold” rating in a report on Friday, October 20th. Finally, Barclays dropped their price objective on Validus from $57.00 to $53.00 and set an “equal weight” rating on the stock in a report on Monday, October 16th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and one has assigned a buy rating to the stock. Validus presently has an average rating of “Hold” and an average target price of $52.80.
Shares of Validus (NYSE VR) opened at $67.47 on Tuesday. The company has a current ratio of 0.95, a quick ratio of 0.95 and a debt-to-equity ratio of 0.52. Validus has a 1-year low of $41.15 and a 1-year high of $67.73. The firm has a market capitalization of $5,510.36, a PE ratio of -78.45, a price-to-earnings-growth ratio of 1.81 and a beta of 1.05.
In other news, President Kean Driscoll sold 6,875 shares of the stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $46.16, for a total value of $317,350.00. Following the transaction, the president now owns 110,858 shares in the company, valued at approximately $5,117,205.28. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In the last quarter, insiders sold 20,625 shares of company stock worth $984,775. Company insiders own 2.33% of the company’s stock.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Zions Bancorporation acquired a new stake in shares of Validus in the 3rd quarter valued at about $116,000. The Manufacturers Life Insurance Company boosted its position in shares of Validus by 10.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 2,382 shares of the insurance provider’s stock valued at $124,000 after purchasing an additional 219 shares during the period. Advisors Asset Management Inc. boosted its position in shares of Validus by 4,598.8% in the 3rd quarter. Advisors Asset Management Inc. now owns 3,947 shares of the insurance provider’s stock valued at $194,000 after purchasing an additional 3,863 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Validus by 48.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,315 shares of the insurance provider’s stock valued at $202,000 after purchasing an additional 1,410 shares during the period. Finally, Paragon Capital Management Ltd acquired a new stake in shares of Validus in the 4th quarter valued at about $211,000. 95.50% of the stock is owned by hedge funds and other institutional investors.
Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.
Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.